- Home
- CBFV vs INBX Comparison
CBFV vs INBX Comparison
Compare CBFV & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- INBX
- Stock Information
- Founded
- CBFV 1901
- INBX 2010
- Country
- CBFV United States
- INBX United States
- Employees
- CBFV N/A
- INBX 161
- Industry
- CBFV Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- INBX Health Care
- Exchange
- CBFV Nasdaq
- INBX Nasdaq
- Market Cap
- CBFV 148.0M
- INBX 168.1M
- IPO Year
- CBFV N/A
- INBX 2020
- Fundamental
- Price
- CBFV $28.63
- INBX $11.47
- Analyst Decision
- CBFV Hold
- INBX Hold
- Analyst Count
- CBFV 2
- INBX 1
- Target Price
- CBFV $26.00
- INBX N/A
- AVG Volume (30 Days)
- CBFV 12.9K
- INBX 144.3K
- Earning Date
- CBFV 04-29-2025
- INBX 05-08-2025
- Dividend Yield
- CBFV 3.49%
- INBX 7.40%
- EPS Growth
- CBFV N/A
- INBX N/A
- EPS
- CBFV 2.38
- INBX 112.62
- Revenue
- CBFV $50,028,000.00
- INBX $200,000.00
- Revenue This Year
- CBFV $8.55
- INBX N/A
- Revenue Next Year
- CBFV $9.01
- INBX N/A
- P/E Ratio
- CBFV $12.03
- INBX $0.10
- Revenue Growth
- CBFV N/A
- INBX N/A
- 52 Week Low
- CBFV $20.75
- INBX $10.80
- 52 Week High
- CBFV $33.72
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- CBFV 56.40
- INBX 34.68
- Support Level
- CBFV $26.04
- INBX $10.81
- Resistance Level
- CBFV $28.64
- INBX $12.06
- Average True Range (ATR)
- CBFV 0.77
- INBX 1.00
- MACD
- CBFV 0.13
- INBX -0.19
- Stochastic Oscillator
- CBFV 93.24
- INBX 18.52
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.